Study follow-up for people who had a kidney transplant
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows adults who previously received vonsetamig in an earlier study and then got a kidney transplant while enrolled. It mainly looks at what happens after the transplant and helps doctors understand outcomes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You got at least one dose of vonsetamig in the earlier study (R5459-RT-1944, NCT05092347).
- You received a kidney transplant while you were enrolled in that earlier study, after tissue compatibility testing (“crossmatching”).
- You are willing and able to come to clinic visits and do study procedures.
- You (or a legally allowed representative) can sign informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with chronic kidney disease who are not on dialysis. It aims to better understand kidney health and test what care or monitoring might help over time.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This is a follow-up study for people who already participated in the STEPS research project about improving fairness in organ transplants. Researchers want to track how participants are doing over time and learn more about transplant outcomes.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study checks samples from people after a kidney transplant to better understand how treatment is working at a biological (molecular) level. It may help doctors improve follow-up care and therapy over time.
Hear when a new Chronic Kidney Disease (CKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.